GeneDx Holdings - 5 Year Stock Price History | WGS
Historical daily share price chart and data for GeneDx Holdings since 2020 adjusted for splits and dividends. The latest closing stock price for GeneDx Holdings as of May 08, 2025 is 56.36.
- The all-time high GeneDx Holdings stock closing price was 851.73 on February 12, 2021.
- The GeneDx Holdings 52-week high stock price is 117.75, which is 108.9% above the current share price.
- The GeneDx Holdings 52-week low stock price is 19.16, which is 66% below the current share price.
- The average GeneDx Holdings stock price for the last 52 weeks is 60.51.
| GeneDx Holdings Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 87.0366 | 79.6300 | 116.9700 | 56.3600 | 56.3600 | -26.67% |
| 2024 | 32.5090 | 2.6400 | 84.0200 | 2.6400 | 76.8600 | 2694.91% |
| 2023 | 7.2365 | 9.2400 | 17.1600 | 1.2400 | 2.7500 | -68.43% |
| 2022 | 61.4181 | 150.4800 | 154.1100 | 7.3920 | 8.7120 | -94.08% |
| 2021 | 377.1533 | 354.7500 | 851.7300 | 145.2000 | 147.1800 | -59.60% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.609B | $0.305B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.189B | 25.92 |
| Elevance Health (ELV) | United States | $94.312B | 12.17 |
| CVS Health (CVS) | United States | $84.478B | 10.50 |
| Cencora (COR) | United States | $59.063B | 20.54 |
| Natera (NTRA) | United States | $21.643B | 0.00 |
| DiDi Global (DIDIY) | China | $20.379B | 30.93 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.707B | 0.00 |
| Solventum (SOLV) | United States | $11.330B | 10.56 |
| ICON (ICLR) | Ireland | $11.213B | 10.42 |
| CochLear (CHEOY) | Australia | $11.158B | 0.00 |
| Doximity (DOCS) | United States | $10.895B | 56.66 |
| Revvity (RVTY) | United States | $10.796B | 18.58 |
| Viatris (VTRS) | United States | $10.198B | 3.25 |
| Medpace Holdings (MEDP) | United States | $8.622B | 22.90 |
| Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
| Avantor (AVTR) | United States | $8.136B | 11.82 |
| HealthEquity (HQY) | United States | $7.933B | 39.03 |
| Charles River Laboratories (CRL) | United States | $6.727B | 13.18 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.028B | 23.75 |
| BrightSpring Health Services (BTSG) | United States | $4.015B | 37.16 |
| Sotera Health (SHC) | United States | $3.733B | 21.21 |
| Alignment Healthcare (ALHC) | United States | $3.071B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.969B | 34.06 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.277B | 2.42 |
| Premier (PINC) | United States | $2.111B | 14.45 |
| Ardent Health Partners (ARDT) | United States | $2.028B | 8.66 |
| Progyny (PGNY) | United States | $2.006B | 44.19 |
| PACS (PACS) | United States | $1.603B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.454B | 27.07 |
| Agilon Health (AGL) | United States | $1.403B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.233B | 9.38 |
| Teladoc Health (TDOC) | United States | $1.203B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.960B | 0.00 | |
| CareDx (CDNA) | United States | $0.822B | 12.84 |
| AMN Healthcare Services Inc (AMN) | United States | $0.749B | 5.92 |
| Embecta (EMBC) | United States | $0.725B | 4.97 |
| QDM (QDMI) | Hong Kong, SAR China | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.649B | 12.72 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 13.73 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.415B | 34.17 |
| LifeMD (LFMD) | United States | $0.364B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.347B | 0.00 |
| SBC Medicals (SBC) | United States | $0.332B | 0.00 |
| DocGo (DCGO) | United States | $0.245B | 10.00 |
| Oncology Institute (TOI) | United States | $0.208B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.178B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.75 |
| KindlyMD (KDLY) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |